Junping Chen, M.D., PHD
SVP Medical, US & Chief Medical Officer, China
Dr. Chen joined CASI in September 2020 as Medical Director. She was appointed as the Chief Medical Officer of CASI China in January 2022.
Dr. Chen was a researcher at University of Oklahoma Health Sciences Center. She has published seven peer reviewed papers, includng the one that was published in Journal of Nature Nanotechnology which has been cited over 800 times. Dr. Chen has granted four international patents related to her research achievement.
Dr. Chen holds a BS of Clinical Medicine and an MS in Immunology from Harbin Medical University and a PhD in Neuroscience from the University of Oklahoma Health Sciences Center.